Mr. Oren Shuster reports

AVANT AND IMC EXECUTE BLK MKT(TM) TRADEMARK LICENSING AGREEMENT FOR THE GERMAN MEDICAL CANNABIS MARKET

IM Cannabis Corp. and Avant Brands Inc. have signed an international trademark licensing agreement granting Adjupharm GmbH, IM Cannabis's German subsidiary (IMC Germany), the exclusive right to launch the BLK MKT brand in the German medical cannabis market. The licensing agreement constitutes another major milestone with respect to the relationship between the two cannabis companies.

Under the terms of the trademark licence agreement, Avant's subsidiary will grant IMC Germany the licence to utilize Avant's BLK MKT cannabis brand for use on its medical cannabis products. All such products will contain cannabis cultivated exclusively by Avant and subsequently exported to Germany. The collaboration between the two companies anticipates a positive outcome in the emerging German medical cannabis market, especially following the recent legalization by the government on April 1.

The licensing agreement signals IM Cannabis's commitment to implementing a premium strategy in Germany as well as in Israel and acts as another step to establish Avant's position in the ultrapremium segment in Israel and Germany. IM Cannabis and Avant have had a productive partnership so far, combining Avant's premium cannabis products with IM Cannabis's sales, marketing and distribution expertise in Israel. Both companies believe the licensing agreement will enhance the companies' capabilities to meet the demands of the German market.

"By evolving our partnership with Avant, we continue to improve our supply chain and ability to provide ultrapremium, quality brand and product to the German medical cannabis market," Oren Shuster, chief executive officer of IM Cannabis, commented.

"We believe that our collaboration with Avant will continue to accelerate the strong momentum we have established in the German medical cannabis market," stated Richard Balla, CEO of IMC Germany.

"This agreement represents another major milestone with respect to our highly successful multiyear partnership with IMC," said Norton Singhavon, CEO, Avant Brands.

"We are very excited to be working with IMC's German team," said David Lynn, chief operating officer, Avant Brands. "We are confident that they will do an outstanding job launching the BLK MKT brand in Germany."

Avant's three largest cultivation facilities all hold ICANN GAP (good agricultural practice) and GACP (good agricultural and collection practices) certifications; thus, Avant is positioned to potentially distribute its premium cannabis flower into international markets.

IMC Germany is the sixth-largest distributor of medical cannabis flowers in Germany and is No. 1 in sales per stock-keeping unit, growing 180 per cent in 2023.

About IM Cannabis Corp.

IM Cannabis is an international cannabis company that provides premium cannabis products to medical patients in Israel and Germany, two of the largest medical cannabis markets. The company has recently exited operations in Canada to pivot its focus and resources to achieve sustainable and profitable growth in its highest-value markets, Israel and Germany. The company leverages a transnational ecosystem powered by a unique data-driven approach and a globally sourced product supply chain. With an unwavering commitment to responsible growth and compliance with the strictest regulatory environments, the company strives to amplify its commercial and brand power to become a global high-quality cannabis player.

We seek Safe Harbor.